Price Alert

Moleculin Biotech Inc. (MBRX)

NASDAQ: MBRX · Real-Time Price · USD

0.67

0.02 (3.43%)

At close: Aug 15, 2025, 3:59 PM

0.69

2.85%

After-hours: Aug 15, 2025, 07:43 PM EDT

Moleculin Biotech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	7.56M	7.72M	4.28M	9.4M	10.85M	16.82M	23.55M	24.58M	32.17M	37.27M	43.15M	50.39M	58M	66.1M	70.9M	75.18M	79.51M	86.29M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	10K	n/a
Other Long-Term Assets	999K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	395K	n/a
Receivables	n/a	6K	20K	n/a	9K	n/a	99K	n/a	12K	n/a	22K	10K	33K	27K	45K	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-12K	n/a	-22K	n/a	-33K	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.52M	n/a	331K	n/a	457K	n/a	n/a	3.02M	n/a	2.02M	n/a	n/a	n/a	n/a	n/a	1.89M	2.33M	1.73M
Total Current Assets	9.08M	9.34M	5.19M	11.61M	13.73M	18.96M	26.27M	27.6M	35.38M	39.29M	45.6M	53.49M	61.32M	67.26M	72.5M	77.07M	81.84M	88.02M
Property-Plant & Equipment	370K	525K	583K	640K	696K	740K	796K	772K	587K	625K	678K	731K	785K	393K	445K	484K	550K	617K
Goodwill & Intangibles	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M
Total Long-Term Assets	12.52M	11.67M	11.73M	11.79M	11.84M	11.89M	11.94M	11.92M	11.73M	11.77M	11.83M	11.88M	11.93M	11.54M	11.59M	11.63M	11.7M	11.77M
Total Assets	21.59M	21.01M	16.93M	23.39M	25.57M	30.84M	38.22M	39.52M	47.12M	51.06M	57.42M	65.37M	73.25M	78.8M	84.09M	88.7M	93.53M	99.78M
Account Payables	3.72M	2.71M	2.03M	2.55M	2.83M	2.1M	2.5M	2.01M	4.14M	1.94M	2.1M	3.57M	3.18M	2.22M	1.36M	1.39M	1.5M	1.93M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-88K	n/a	n/a	n/a	n/a	-98K	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	124K	120K	116K	112K	109K	100K	88K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	7.91M	-124K	1.27M	-116K	1.53M	1.99M	3.35M	n/a	n/a	n/a	1.86M	2.25M	2.44M	1.66M	1.56M	1.8M	1.61M	1.72M
Total Current Liabilities	7.91M	6.9M	5.36M	5.59M	5.75M	5.41M	6.82M	3.89M	6.55M	5.03M	4.82M	6.36M	5.86M	4.83M	3.62M	3.66M	3.35M	4.58M
Long-Term Debt	292K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	20.55M	13.75M	5.23M	9.93M	1.7M	3.4M	4.86M	1K	2K	38K	77K	228K	649K	1.25M	1.41M	3.71M	5.39M	6.56M
Total Long-Term Liabilities	20.84M	14.07M	5.59M	10.32M	2.12M	3.85M	5.33M	497K	293K	346K	412K	593K	1.04M	1.3M	1.48M	3.79M	5.48M	6.69M
Total Liabilities	28.76M	20.97M	10.95M	15.91M	7.87M	9.26M	12.14M	4.38M	6.85M	5.38M	5.23M	6.96M	6.9M	6.14M	5.1M	7.44M	8.83M	11.27M
Total Debt	292K	450K	478K	506K	532K	559K	574K	496K	291K	308K	451K	477K	486K	127K	159K	190K	220K	249K
Common Stock	30K	14K	3K	3K	3K	2K	33K	30K	30K	30K	29K	29K	29K	29K	29K	29K	29K	28K
Retained Earnings	-167.44M	-159.8M	-153.37M	-151.49M	-140.89M	-136.57M	-131.6M	-121.33M	-115.73M	-109.75M	-101.83M	-95.06M	-86.45M	-79.68M	-72.81M	-69.98M	-65.61M	-61.36M
Comprehensive Income	-38K	-38K	-41K	4K	-10K	-18K	-9K	-3K	7K	8K	12K	3K	22K	53K	41K	39K	55K	61K
Shareholders Equity	-7.17M	42K	5.98M	7.48M	17.7M	21.59M	26.07M	35.14M	40.27M	45.68M	52.19M	58.42M	66.36M	72.67M	78.99M	81.26M	84.7M	88.52M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	10K	n/a